Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 144.10M
June 30, 2026 107.76M
March 31, 2026 93.93M
December 31, 2025 83.85M
September 30, 2025 41.44M
June 30, 2025 41.44M
March 31, 2025 41.44M
December 31, 2024 38.33M
September 30, 2024 38.26M
June 30, 2024 38.26M
March 31, 2024 25.60M
December 31, 2023 25.57M
September 30, 2023 25.57M
June 30, 2023 25.57M
March 31, 2023 11.94M
December 31, 2022 9.902M
September 30, 2022 9.902M
June 30, 2022 8.832M
March 31, 2022 8.832M
December 31, 2021 8.832M
Date Value
September 30, 2021 8.784M
June 30, 2021 5.967M
March 31, 2021 5.967M
December 31, 2020 5.966M
September 30, 2020 5.966M
June 30, 2020 5.966M
March 31, 2020 3.580M
December 31, 2019 2.420M
September 30, 2019 2.420M
June 30, 2019 2.295M
March 31, 2019 2.226M
December 31, 2018 1.470M
September 30, 2018 1.470M
June 30, 2018 1.470M
March 31, 2018 1.450M
December 31, 2017 1.235M
September 30, 2017 0.9396M
June 30, 2017 0.9396M
March 31, 2017 0.9392M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Indaptus Therapeutics, Inc. 133.24M
Cue Biopharma, Inc. 7.754M
Yarrow Bioscience, Inc. 11.47M
Faeth Therapeutics, Inc. 25.84M
Pyxis Oncology, Inc. 83.51M